SARS-CoV-2 Infection Precipitating VT Storm in Patients With Cardiac Sarcoidosis

JACC Clin Electrophysiol. 2023 Nov;9(11):2342-2346. doi: 10.1016/j.jacep.2023.07.021. Epub 2023 Sep 20.

Abstract

The authors describe 3 patients presenting with cardiac sarcoidosis (CS) flare and ventricular tachycardia (VT) storm following infection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19. COVID-19-related cardiac manifestations can vary and include arrythmias, myocarditis, and exacerbation of underlying cardiovascular disease. The exact mechanism of myocardial involvement is not clear but may include abnormal host immune response and direct myocardial injury, thereby predisposing to enhanced arrhythmic risk. Arrhythmias account for 20% of COVID-19-related complications with ventricular arrythmias occurring in 5.9% of cases. Further studies are needed to better understand mechanisms underlying the intersection between COVID-19 infection and inflammatory cardiomyopathies.

Keywords: cardiac sarcoidosis; coronavirus disease 2019; myocarditis; severe acute respiratory syndrome coronavirus; ventricular tachycardia.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arrhythmias, Cardiac / complications
  • COVID-19* / complications
  • Cardiomyopathies* / complications
  • Humans
  • Myocarditis*
  • SARS-CoV-2
  • Sarcoidosis* / complications
  • Tachycardia, Ventricular*